Diabetes is a medical term to illustrate a condition where the human body cannot control the amount of sugar in the blood, causing the blood-sugar levels to be high. Diabetic patients are categorized by two types of diabetes: insulin-dependent and non-insulin dependent. Both types of diabetes may lead to serious complications including blindness, kidney failure, heart attack, stroke, hypertension, and circulatory disorder leading to lower-extremity amputations.

Lifestyle changes are inevitable for diabetic patients, from simple self-care to medical treatment, or to an extreme point hospitalization. Financially, diabetes may take a toll on a patient’s life but the most important thing is to keep emotion in check. Diabetes may not temporary; patients might need to live with it throughout their life.

One of the many ways on how to cope with diabetes is to ask for help. Diabetics must know they are not alone; there are many support groups for diabetic patients nowadays to help them cope with the disease. Knowing other people who have been, or are going through the same path is a good ground to share experiences and understanding of their plight, which is needed by most patients. Other than support groups, diabetic patients may also talk to their health care provider, dietician, diabetes educator, and pharmacist for any diabetes-related questions or concerns.

For diabetics, strategies and skills to cope with daily challenges can be built and learnt. Learning proper ways to handle daily stress and to control the frequent emotional ups and downs is a must, but most of all, people diagnosed with diabetes need to take control of their life by learning all there is to know to understand how diabetes will affect their body and what needed to be done to control the blood glucose levels. Having diabetes must not prevent you from having a normal life; follow doctor’s advice and maintain both your lifestyle and also your blood levels.

Another way to better cope with diabetes is to do it with the support of family and friends. Otherwise, one may feel alone and isolated when dealing with diabetes. People tend to be stronger when they have a strong support system; let family and friends be involved in diabetes management.

Smoking must be avoided as it increases the risk of heart disease, and alcohol must only be taken in small quantities. In addition, aromatherapy is believed to influence the pancreas and so you can add Eucalyptus and lemon oils to your bathwater, or have a massage of almond oil which will, if nothing else, make you feel better.

Herbal remedies, along with your orthodox treatment, can sometimes help to improve your sense of well-being. Certain vitamins, such as A, B, C and E may well help to avoid long term complications. Chromium which helps boost the action of insulin, Magnesium which may decrease insulin resistance and zinc may all assist the body to cope with diabetes. However, in all instances consultation with your doctor is essential to ensure that the addition of these herbal remedies will not conflict with the medication.

A new research in the United States showed that those individuals who seriously implement their diabetes treatment cut the possibilities of being admitted to the hospital.

The extensive survey involved more than 15,000 commercially insured individuals with medical claim of diabetes diagnosis who were observed over the period of one year, and it was conducted by Prime Therapeutics. Furthermore, the research was released in the Journal of Managed Care Pharmacy.

Of those evaluated, 73.9 percent were found to stay to their treatment, while 26.1 percent failed to stick with their diabetes medication.

With more than 23 million people in the United States having been identified to have diabetes mellitus, and an added 1.6 million being identified every year, there are concerns with regard to deficiency to stick to take their medicine, particularly because of increased medical expenses and its unhelpful effect on the efficiency of the treatment.

Moreover, Patrick Gleason, Prime Therapeutics’ director of clinical outcomes assessment, said that their study discovered enthusiast people had $1,010 lower medical expenses during the year. Gleason also said that besides the medical expenses savings, patients that stay to their medicines are possible yo have improved health and enhanced the quality of their life.

Yet in this research, they also found out that 25 percent of patients do not adhere to their diabetes treatment, so the medical community must look for ways to boost observance for those people most at-risk due to their condition.

Eli Lilly and Medtronic, the biggest manufacturer of heart devices in the world, announced that they are working out a treatment for Parkinson’s disease.

This treatment will deliver an experimental drug directly to the brain of a patient who has this kind of condition. The approach will mix a protein coming from Lilly well-known to protect the function of neurons with a system from Medtronic that delivers the drug to a main portion of the human brain.

Both companies stated today that the medication is in the first phases of development, and working as one may proffer the best opportunity of success. The combination of biological drug of Lilly and the medical technology of Medtronic is intended to create a treatment that can break the barrier of blood-brain, one of the largest blockages for curing neurological diseases.

While it protects the patient’s brain from infection, the barrier makes it hard to obtain anti-bodies employed to cure some illnesses into the brain. According to Stephen Oesterle, the senior vice-president of Medtronic for medicine and technology, they have brought it to the appropriate place because protein cannot cross the barrier of blood-brain.

Stephen also said that they employ a navigation system and an implantable pump that accumulates the biologic and incessantly instills it to impersonate human biology. On the other hand, statistics showed that as many as 10 million individuals all over the globe have suffered from Parkinson’s disease, a degenerative illness caused by the brain neuron’s death that generate the chemical dopamine used to manage movement.

The outcome is loss of coordination, stiffness, weakness of muscle, tremors and in the end death. Current medicines like L-dopa medicine ease symptoms. There is no cure. The new protein protects the function of neurological cells that generate the dopamine missing in people with Parkinson’s disease.

The Food and Drug Administration (FDA) approved NovoTTF, a device that uses electric energy to treat brain cancer.

NovoTTF, approved for those patients who have malignant brain tumors identified as glioblastoma multiforme, adds a potential latest option for chemotherapy for patients who have suffering from advance tumors in brain.

Moreover, the device supplies low-intensity electrical fields straight to the scalp of a patient thru four electrodes. The electrical fields show to obstruct with the course of cell division, stopping the development of tumors.

In a clinical trial done in 237 participants with glioblastoma multiforme, the most well-known and destructive form of cancer in the brain, those who wore the device live as long as participants who underwent chemotherapy for almost six months.

However, the device-wearers did not have the incapacitating side effects of severe infection, anemia, fatigue and nausea that are common to chemotherapy. Those who wore the device did have more neurological side effects, such as headaches and convulsions, compared with those who received chemotherapy.

Wearing NovoTTF can also be a headache because this device weighs six pounds and is carried in a satchel for whole day, while four electrodes temperate the shaved areas of the patient’s scalp. Nevertheless, a survey of the two groups recommended that patients who wore NovoTTF had a better quality of life than those who underwent chemotherapy.

This device is only intentional more or less as a last option from radiation therapy; chemotherapy and surgery are still the standard way s of treating to slow down the development of cancer in the brain.

An international diabetes federation has recommended bariatric surgery as an effective treatment for severely obese people with Type 2 DM.

In a three-day 2nd Annual World Congress for International Therapies for Type 2 Diabetes, various organizations have called for bariatric surgery to be considered as a cost-effective treatment of eligible patients, to help stem the serious complications that can result from diabetes.

According to reports, the treatment was primarily developed as a treatment for severely obese patients. However, recent studies showed that this surgical procedure can also improve blood sugar levels and reduce the need for diabetes medications. One researcher said in an interview that based on the study that they conducted earlier, they have found that patients who have undergone this surgery do not only gained health benefits, but also save considerable amount of money.

Catherine Keating of Deakin University in Melbourne, Australia noted that this provides a strong rationale for the implementation of this treatment on economic grounds. This statement was reiterated by David Reed Flum of the University of Washington School of Medicine, saying that now is the perfect time for governmental agencies who are involved in providing health care benefits to understand the way resources are currently being applied to the treatment and prevention of diabetes.

He added that people who are involved in this issue must also consider the future impact of this surgery to the society once it becomes a meaningful part of the public health response to the diabetes epidemic. Over the years, obesity has been found to contribute to approximately 55 percent of Type 2 diabetes cases all over the world. Researchers said that there is a strong possibility for this record to rise further unless the people involved take a stand to stop this problem.

Researchers successfully cured man with leukemia and HIV infection after he underwent blood stem cell transplant in 2007.

According to accounted data, an American who lived in Berlin has been cured by a blood stem cell transplant to treat his leukemia. He received a good match of donor, who had a gene that perfectly match his own and give natural protection and resistance in HIV virus.

Three years after the transplant, the recipient was observed to be cleared of any signs of leukemia and even HIV infection. This finding is reported in the journal Blood.

Dr. Michael Saag, at the University of Alabama at Birmingham, said that the result finding is an interesting proof-of-concept that with the help of an extraordinary measure for patients who suffered HIV, are now has its full potential to be cured.

However, Dr. Saag noted that the therapy is far too risky to become the standard therapy for patients even to those who found their matched donors.

Sag is the former chairman of the HIV Medication Association. It is an organization of specialist in treating AIDS.

Bone marrow transplant is the most common kind of transplant to treat cancer. However, bone marrow or the most commonly known blood stem cells, and the process of transplanting them in treating the illness is yet unknown especially to those healthy individuals.

The process usually involves destruction of the person’s native immune system, using radiation and some powerful drugs, and then replacing it will the donor’s blood stem cells to develop a new immune system. Based on medical reports, experts accounted a five percent and more in mortality rate due to complications after the procedure.

He stressed that they did not suggest applying the particular approach to healthy people due to the risk it possess that is too high.

According to a study in Sweden, fertility treatment may not be bounded to an increased risk of having cancer in spite of the hormones used.

In a research done by Bengt Kallen and colleagues, they studied the registry information of 24,000 women from 1982-2006 who gave birth after in-vitro fertilization (IVF) and compared the rates of cancer in these women with 1.4 million women in the general population of Sweden who also gave birth in those years.

Less than two percent of those women in the group of IVF built up one or more cancers during the standard period of follow-up for eight years, compared with nearly five percent of the other group. Furthermore, some earlier studies had recommended that fertility medicines may be connected with ovarian, breast and uterine cancers.

In addition, after counting for motherly age, the figure of prior status of smoking and pregnancies, the general risk of having cancer was almost five percent lower for women who had undergone IVF. Kallen also said that a couple who needs to have IVF does not be afraid that the hormone therapy used, at least those employed in Sweden, will take a risk for the women to have cancer.

Moreover, while the risk of having ovarian cancer was more than doubled as high in most women who had IVF as those who did not, Kallen recommended that this may be because the abnormalities in ovarian role that can both boost the risk for having cancer and the risk of having infertility, therefore the need for IVF.

He added that the risk for two most common cancers, cervical and breast cancer was drastically lower than anticipated. Kallen also added that this may also because of women who acquire IVF are being healthier than the standard or, more possible, that those who were treated with IVF may undergo more mammography and cervical examinations.

Merck said that they settled to stop testing Isentress, the company’s HIV drug, after initial trial results showed that the treatment was not as useful as control treatment.

In addition, the results also showed that it is not also effective as a standard treatment. The research about the drug was designed to evaluate a once a day dosage of Isentress with twice per day of similar drug for its effectiveness.

The company thought that the once a day dosage can be used to substitute the twice per day treatment with the anti-HIV medicine and was ready to present its application for the approval of the regulatory board in 2011.

Moreover, in 2007 the Food and Drug Administration (FDA) approved Isentress and specified to lessen the load of HIV in twice a day dosage. The Isentress is also the preliminary of a group of HIV medicines known as HIV integrase inhibitors.

Furthermore, Reuters said that the drug brought Merck yearly sales of $777 million for the first nine months last year. The study also showed that after one year of treatment, 83.2 percent of people treated with once a day dosage lowered the loads of their HIV to an unnoticeable viral level, compared with 88.9 percent of individuals treated with twice per day dosage of Isentress.

The variation is statistically considerable. Also, the variation was found typically among people with a high viral load that means the once a day dosage may not be sufficient to restrain the viral development. Anti-viral medicines are frequently used to lessen the viral load even though a low viral load does not always mean that the patient is free from risk of having AIDS.

The Centers for Disease Control and Prevention (CDC) said that over one million people in the United States are living with HIV and 21 percent are not aware that they already acquired the HIV infections.

Researchers from Rush University Medical Center found out that transcranial magnetic stimulation (TMS) therapy can be a helpful and enduring treatment for depression symptoms.

TMS therapy is a non-drug and non-invasive approach that brings greatly focused magnetic field pulses to a particular cortex in order to fuel the parts of the brain connected to depression. The results of this research were published in Brain Stimulation, October 2010 issue.

In addition, this study finds out the strength and enduring effects of TMS. These pulses are of the same greatness to the magnetic field made during the magnetic resonance imaging (MRI) scan. The frequent short occurrences of magnetic energy established through the scalp stimulate neurons nearby and in linked parts in the brain.

Furthermore, TMS obtained permission from the United States Food and Drug Administration (FDA) last October 2008. This new treatment choice is secure and helpful, severe antidepressant therapy, but there is narrow details on its enduring benefits.

According to Dr. Philip G. Jancak, psychiatry professor at Rush University Medical Center and the study chief researcher, this is the only summarize, continuance, potential research which evaluates the durability of severe TMS advantage in patients with major depression.

Moreover, in the research, 301 people who are suffering from major depression were randomly given to receive con or dynamic TMS in a severe, six weeks, controlled assessment. Patients who took action then suffered a three weeks, change period where they were shrank off of con or dynamic treatment of TMS and began on a typical antidepressant for maintenance.

After any thriving severe treatment for depression like electroconvulsive (ECT), antidepressant medications or TMS therapy, it is a common practice to initiate medication for maintenance to reduce the possibility of relapsing. Also, TMS was effectively used as an alternating rescue approach to prevent impending relapse in 84 percent of patients.

There are numerous individuals suffering from cancer nowadays that are hopeless for a cure and still often conventional treatments like chemotherapy just appear to make the patient sicker. Though it’s necessary to talk to a doctor and unite with them is searching for the precise cancer treatments. Absolutely, there are few natural treatments for cancer that must be discussed with the doctor, which may either help to eliminate cancer cells or aid to alleviate the consequences of radiation therapy and chemotherapy.

Glyconutrients as a Natural Cancer Treatment

Glyconutrients are becoming popular for their advantageous effects yet it’s just since about 1996 that the physicians have truly had this entailed in their review. Physicians who qualified before 1996 may need to be asked regarding their usage or perform more analysis in it. Glyconutrients don’t necessarily treat cancer but they can aid with lessening side effects of the conventional treatments and boost their efficiency.

Utilizing Ozone Therapy

Cancer cells can’t live in the presence of natural oxygen as they are known anaerobic. Treatments like ozone therapy may therefore be very efficient in destroying cancer cells while tendering numerous other advantages for the body too. Consult to the doctor about what sort of ozone therapy would be advantageous and how it can be included in cancer treatments.

Anti Cancer Dieting

Anti-cancer dieting is specifically valuable in avoiding, instead of actually curing cancer. Still, is a person presently is suffering from cancer, then it isn’t too late to utilize anti-cancer dieting plans to aid improve the health and positively prevent the spreading of cancer.

The benefit with numerous natural cancer treatments is that there are typically no negative side effects as there are with some other treatments, yet these must still not be followed without due consideration to the exception of other treatments. Incorporating these valuable natural treatments with conventional cancer treatments and develop the chance of the patient to overcome cancer.